SavedAdd your journal

Journals / Arşiv Kaynak Tarama Dergisi / 2020 / Cilt: 29 - Sayı: 1

Neuropsychiatric Effects of Synthetic Cannabinoids

Sentetik Kannabinoidlerin Nöropsikiyatrik Etkileri

Mirac Barış USTA
Armağan ARAL
Bahattin AVCİ
Pages
29–36
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Knowing the neuropsychiatric conditions that may occur as a result of the use of synthetic cannabinoids and distinguishing them from cannabis use will guide the arrangements to improve the functionality of the neurorehabilitation process.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Synthetic cannabinoids are common names of many compounds produced in a laboratory environment that mimic the psychoactive effects of cannabis.
📊
Key Findings & Data:Due to the increasing rate of usage, there are many studies needed to better understand the effects, reduce the consumption rate and facilitate the elimination of the negative effects it creates.
💡
Conclusion & Impact:Knowing the neuropsychiatric conditions that may occur as a result of the use of synthetic cannabinoids and distinguishing them from cannabis use will guide the arrangements to improve the functionality of the neurorehabilitation process.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Synthetic cannabinoids are common names of many compounds produced in a laboratory environment that mimic the psychoactive effects of cannabis. The use of synthetic cannabinoid is a public health problem that has become widespread among young people in recent years. Due to the increasing rate of usage, there are many studies needed to better understand the effects, reduce the consumption rate and facilitate the elimination of the negative effects it creates. Knowing the neuropsychiatric conditions that may occur as a result of the use of synthetic cannabinoids and distinguishing them from cannabis use will guide the arrangements to improve the functionality of the neurorehabilitation process.

Özet

Sentetik Kannabinoidler esrarın psikoaktif etkilerini taklit eden laboratuar ortamında üretilmiş birçok bileşiğin ortak adıdır. Sentetik Kannabinoid kullanımı son yıllarda gençler arasında hızla yaygınlaşan bir halk sağlığı sorunudur. Kullanım oranının gün geçtikçe artması nedeniyle etkilerinin daha iyi anlaşılabilmesi, tüketim hızının azaltılabilmesi, yarattığı olumsuz etkilerin giderilmesinin kolaylaştırılabilmesi için birçok çalışmaya ihtiyaç vardır. Sentetik kannabinoid kullanımı sonucunda ortaya çıkabilecek nöropsikiyatrik durumların bilinmesi ve esrar kullanımından ayırt edilmesi, nörorehabilitasyon sürecinin işlevselliğini artırmaya yönelik düzenlemelere yol gösterecektir.

🔖

Cite This Article

USTA, M. B., ARAL, A., AVCİ, B. (2022). Neuropsychiatric Effects of Synthetic Cannabinoids. Arşiv Kaynak Tarama Dergisi, Cilt: 29 - Sayı: 1, 29–36. https://ajindex.com/articles/449087

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Pacher, P., S. Bátkai, and G. Kunos, The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev. 2006;58:389-462.
  2. Spaderna, M., P.H. Addy, and D.C. D’Souza, Spicing things up: synthetic cannabinoids. Psychopharmacology, 2013;228:525-40.
  3. Winstock, A.R. and M.J. Barratt, Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug Alcohol Depend. 2013;131:106-111.
  4. Kalyoncu, A., B. Ünlü, and U. Taştan, Gençlerin tehlikeli oyunu: Sentetik kannabinoidler (Bonzai) üzerine bir gözden geçirme. Bağımlılık Dergisi. 2014;15:150-5. Auwärter, V. et al. Spice’and other herbal blends: harmless incense or cannabinoid designer drugs? J. Mass Spectrom. 2009;44:832-7.
  5. Castellanos, D. et al. Synthetic cannabinoid use: a case series of adolescents. J Adolesc Health. 2011;49:347-9.
  6. Tournebize, J., V. Gibaja, and J.-P. Kahn, Acute effects of synthetic cannabinoids: update 2015. Subst Abuse. 2017;38:344-66.
  7. Hoyte, C.O., et al. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012;60:435-8.
  8. Harris, C.R. and A. Brown, Synthetic cannabinoid intoxication: a case series and review. J Emerg Med. 2013;44:360-6.
  9. Alıcı, T. and T. Uzbay, Kannabinoidler: Ödüllendirici ve bağımlılık yapıcı etkilerinin nörobiyolojisi ve nöropsikofarmakolojisi üzerine bir gözden geçirme. Bağımlılık Dergisi. 2006;7:140-9.
  10. Khan, M., et al. Catatonia secondary to synthetic cannabinoid use in two patients with no previous psychosis. Am J Addict. 2016;25:25-7.
  11. Simmons, J.R. et al. Intoxication from smoking “spice”. Ann Emerg Med. 2011;57:187-8.
  12. Akpinar, A., et al. Cannabis Use Disorder, Synthetic Cannabinoid and Amotivational Syndrome: A Case Report. Bağımlılık Dergisi. 2015;16:35-8.
  13. Seely, K.A. et al. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry., 2012;39:234-43.
  14. Martinotti, G., et al. Prevalence and intensity of basic symptoms among cannabis users: an observational study. Am J Drug Alcohol Abuse. 2011;37:111-6.
  15. Dragt, S., et al. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr Scand. 2012;125:45-53.
  16. Linszen, D. and T. van Amelsvoort, Esrar ve psikoz: seyir ve akla uygun biyolojik mekanizmalar hakkında bir güncelleme. Curr Opin Psychiatry. 2007;3:119. Martinotti, G., et al., Synthetic